Skip to main content

Cannabis Bioscience International Holdings, Inc.

corporate_fare Company Profile

Cannabis Bioscience International Holdings, Inc.

CBIH·OTC·Industrial Applications And Services·CIK 0001411057

Cannabis Bioscience International Holdings, Inc. operates three distinct businesses. The company was initially formed in Colorado on February 28, 2003, as Fidelity Aircraft Partners LLC, later converting to Fidelity Aviation Corporation on December 16, 2009. It subsequently changed its name to China Infrastructure Construction Corp. on August 24, 2004, then to Hippocrates Direct Healthcare, Inc. on February 28, 2018, and finally to Cannabis Bioscience International Holdings, Inc. on December 6, 2022. Its first business, known as the Pharmacology University Business, focuses on cannabis-related research and education under the trade name Pharmacology University. The second business, the Alpha Research Business, conducts clinical trials, some of which may involve cannabis and CBD products, acting as both a Sponsor and a Contract Research Organization (CRO) under the trade name Alpha Research Institute. The third business, the CBD Business, plans to manufacture, market, and sell CBD products under the name "VitaCookies." The company has filed 10 utility patent applications with the U.S. Patent and Trademark Office (USPTO) and plans to file 10 additional applications. It also holds 12 U.S. trademarks.

Cannabis Bioscience International Holdings, Inc. (OTC:CBIH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors CBIH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cannabis Bioscience International Holdings Reports Near-Zero Cash, Worsening Financials, and Ineffective Controls Amidst Going Concern Warning
  • Going Concern Warning, Ineffective Controls, and Deteriorating Financials Highlight Severe Risks

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$303.02K
Net Income
-$548.82K
Diluted EPS
-$0.00
Op. Cash Flow
-$329.63K
Gross Profit
$262.92K
Operating Income
-$421.37K
Cash & Equivalents
$12.95K
Total Debt
$264.09K
Debt / Equity
-0.23×
Net Margin
-181.1%
Shares Outstanding
11.63B sh
Source: 10-K · filed 2025-09-22 · accession 0001683168-25-007174
Browse all tickers starting with C →
$0.0003
52-week range · as of 2026-04-16 $0.0003 – $0.0008
Market cap
$3.49M
Volume
4.3M (0.4× avg)
3-mo avg 10.8M
Live data · 2026-06-14 06:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CBIH - Latest Insights

CBIH
Apr 16, 2026, 3:39 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0004
Real-time Price: $0.0003 info
Change: -$0.0001 (-25%) info
Market Cap: $3.488M info
CBIH
Feb 19, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0004
Real-time Price: $0.0003 info
Change: -$0.0001 (-25%) info
Market Cap: $3.488M info